Routine screenings in adults could get a bit easier in the future or could be delivered a different way. Here are some changes that are likely to be happening soon.
Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12.
Canadian patients wait a very long time, much longer than in other developed countries, before being able to access new treatments, notes the Conference Board of Canada.